✦ LIBER ✦

Clinical and economical consequences of the combination of metformin with dipeptidyl peptidase inhibitors in type 2 diabetes patients

✍ Scribed by Sicras Mainar, A.; Roldán Suárez, C.; Font Ramos, B.; Navarro Artieda, R.; Ibáñez Nolla, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy of dipeptidyl peptid

✍ Liu, Y.; Hong, T. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Tolerability and pharmacokinetics of met

✍ Herman, Gary A.; Bergman, Arthur; Yi, Bingming; Kipnes, Mark 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 304 KB

Efficacy and Safety of the Dipeptidyl Pe

✍ Charbonnel, B.; Karasik, A.; Liu, J.; Wu, M.; Meininger, G. 📂 Article 📅 2006 🏛 American Diabetes Association 🌐 English ⚖ 148 KB

Efficacy and safety of the dipeptidyl pe

✍ J. Rosenstock; A. J. Lewin; P. Norwood; V. Somayaji; T. T. Nguyen; J. G. Teeter; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Inhibition of dipeptidyl peptidase IV ac

✍ J. R. Lindsay; N. A. Duffy; A. M. McKillop; J. Ardill; F. P. M. O'Harte; P. R. F 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

Efficacy and safety of dipeptidyl peptid

✍ Wu, D.; Li, L.; Liu, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB